U.S. Markets closed

Numinus Wellness Inc. (LKYSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.7778+0.0305 (+4.08%)
At close: 3:59PM EDT
Sign in to post a message.
  • D
    Dino
    Nice report!
    Bullish
  • O
    Oren
    I didn't know they were making that much money already! Wow $$$
  • L
    Lawrence
    The after hours ER yesterday looking very good. Let’s go Numi!
  • S
    Sebastien
    I like what im reading for Q3, will micro dose tonight. Hoping nice little green tomorrow :) Salut !
  • C
    Chris
    -if- volume was to come in, right about now, it could set this up for a pretty decent run.
    Neutral
  • R
    RJ
    Buy buy buy
    Bullish
  • N
    Nate
    Numi C warrants are so undervalued right now. Do yourself a favour and buy some, $0.135 right now
  • U
    Umar
    Congratulations Numinus Wellness Inc in getting the approval for MDMA from Health Canada!
  • A
    Anonymous
    why this thing is not moving even after such a good news?
    Bullish
  • K
    Khan
    This is Atleast a $2 stock. Give it a few months and we'll get there.
    Bullish
  • S
    Simon
    Expecting a gap up at open
    Bullish
  • i
    iPrintDollarz
    here comes the money! MDMA approved.
  • R
    Richard
    The only person here that cares what Chris has to say is Chris 🤷‍♂️.
  • R
    RJ
    Looking good
    Bullish
  • K
    K.
    A happy and proud holder of a sizeable chunk of shares in a company that makes a positive impact in the world having no plan on selling in the next 10+ years from now. After all the most experienced of us know that the stock market is a device for transferring money from the impatient to the patient ...

    Some recent and very interesting news by the way:

    GRADUATES TO TIER 1 ON THE TSX VENTURE EXCHANGE (June)

    “Going forward, we expect to achieve near-term catalysts across our business including clinic acquisitions, new intellectual property, MDMA and psilocybin compassionate access trials, in-clinic ketamine-assisted therapy and further up-listings in the US and Canada. All of this is aimed at creating shareholder value, and supporting our ambition to help as many people as possible heal and be well,” said Payton Nyquvest, President, CEO and Chair.

    NUMINUS FILES U.S. PROVISIONAL PATENT APPLICATION FOR A PROPRIETARY RAPID PRODUCTION PROCESS FOR PSILOCYBE AND OTHER PSYCHOACTIVE FUNGI SPECIES (June)

    "The sustainable, reproducible and easily scalable process will be used to rapidly generate therapeutic products from psychoactive fungi species that contain psilocybin, other psychoactive compounds and a range of additional beneficial compounds, some of which Numinus researchers characterized for the first time in psychedelic fungi."

    NUMINUS WELLNESS TO ACQUIRE NEUROLOGY CENTRE OF TORONTO, PLANS TO CREATE CENTRE FOR PSYCHEDELIC NEUROLOGY (July)

    “I continue to be humbled by the quality of people joining Numinus and acting with us on our ambition to help people heal and be well,” said Payton Nyquvest, Numinus CEO and Chair. “The acquisition of NCT reflects our thoughtful expansion strategy to add clinics that offer revenue-generating services, accretive assets and innovative leadership that maintains our position at the forefront of client care and psychedelic-assisted therapy.”
  • R
    Richard
    Where's Chris #$%$ today?
  • A
    Abel
    just added 15k warrants to my position, cheap at 0.15$ CAD
  • A
    Ali
    will this reach 1.40$ anytime soon?
  • O
    Oren
    Load up, buy the dips and hold!
    Biotech companies are going to explode! $$$$ Numi has the first legal Canadian grown mushrooms!
  • P
    Patrick
    strong opening?